Dangerous 'gray-market' weight-loss drugs flooding US as experts warn of risks
High costs and shortages are driving demand for unregulated GLP-1 drugs, prompting FDA alerts about counterfeit Ozempic and calls for stricter enforcement by legal experts.
High costs and shortages are driving demand for unregulated GLP-1 drugs, prompting FDA alerts about counterfeit Ozempic and calls for stricter enforcement by legal experts.
Read the full article at:
Fox News →